BioPivot Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: published stage-by-stage compounded GLP-1 prices, with monthly, quarterly and microdose options
BioPivot scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
then $185/mo ongoing
Tirzepatide
then $242/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Billed separately
Coaching
Not disclosed
No insurance needed · Vetted by our editors
BioPivot is an Arizona-based telehealth platform offering compounded semaglutide and tirzepatide, including microdose plans, through an independent physician group and a named compounding pharmacy. Prices are published by treatment stage: semaglutide runs $168 to $225 a month or $370 to $518 a quarter, and tirzepatide $220 to $350 a month or $528 to $900 a quarter. It also offers peptides, ED care and lab panels.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to BioPivot
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
BioPivot at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $185/mo (after intro offer) ($148 first order)
- What's included
- Medication · Consult
- FDA status
- No FDA warning letter on record
How we scored BioPivot
Each dimension is scored algorithmically from BioPivot’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.5/10At $185/mo (after intro offer), BioPivot runs in line with the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $148.
Effectiveness25%
8.1/10BioPivot offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.4/10Online intake and platform experience (consult included in the price); 6 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.1/10BioPivot's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.9/10BioPivot provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this BioPivot review
Last checked November 2026- Confirmed current pricing across 16 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $123–$350/mo across 16 dose/plan tiers (checked November 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with BioPivot
We walked BioPivot’s public signup flow in November 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1'Start Consultation' on any treatment page opens BioPivot's online intake
- 2The first screen asks about your health goals, then continues into a medical questionnaire
- 3BioPivot says a licensed provider reviews the intake and may ask for more information, labs or a consultation before deciding
- 4If treatment is approved, a partner compounding pharmacy prepares it and ships it to your door
- Each treatment page shows a monthly and a quarterly price for the starter, continuation, maintenance and microdose stages
- A banner on every treatment page offers 20% off the first order with code BIOPIVOT20 and says consultation slots are limited this week
- The homepage promises $0 if you are not approved, but the refund policy keeps a $59 consultation fee once a provider reviews you
- The FAQ names the clinical group and the pharmacy, each with an email and phone number
BioPivot customer support
- Phone
- 520-210-4673
- info@biopivot.co
- Hours
- Monday to Friday, 9 AM to 5 PM
GLP-1 medications BioPivot offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$185 charged each month for the starter stage. Code BIOPIVOT20 takes 20% off the first order.
$400 a quarter (about $133/mo) for the starter stage.
$218 charged each month for the continuation stage. Code BIOPIVOT20 takes 20% off the first order.
$490 a quarter (about $163/mo) for the continuation stage.
$225 charged each month for the maintenance stage. Code BIOPIVOT20 takes 20% off the first order.
$518 a quarter (about $173/mo) for the maintenance stage.
$168 charged each month for the microdosing stage. Code BIOPIVOT20 takes 20% off the first order.
$370 a quarter (about $123/mo) for the microdosing stage.
$242 charged each month for the starter stage. Code BIOPIVOT20 takes 20% off the first order.
$590 a quarter (about $197/mo) for the starter stage.
$315 charged each month for the continuation stage. Code BIOPIVOT20 takes 20% off the first order.
$780 a quarter (about $260/mo) for the continuation stage.
$350 charged each month for the maintenance stage. Code BIOPIVOT20 takes 20% off the first order.
$900 a quarter (about $300/mo) for the maintenance stage.
$220 charged each month for the microdosing stage. Code BIOPIVOT20 takes 20% off the first order.
$528 a quarter (about $176/mo) for the microdosing stage.
Ready to get started?
Plans and promotions change often, so check BioPivot's current pricing and active discounts before you decide.
What we like
- Every treatment page lists monthly and quarterly prices for each stage before you start
- Quarterly plans cost less per month, for example semaglutide starter at $400 a quarter versus $185 a month
- Names its clinical group (Elite Care Health) and its pharmacy (Rx Ave Health) with contact details
- Lower-cost microdose plans for both semaglutide and tirzepatide
- Phone support with posted weekday hours, plus email and a contact form
- Code BIOPIVOT20 takes 20% off the first order
Watch-outs
- The price rises as you move from the starter stage to maintenance, up to $350 a month for tirzepatide
- The homepage says plans start at $149 a month, but no GLP-1 plan on the site is priced that low
- The homepage says you pay $0 if not approved, but the refund policy keeps a $59 consultation fee
- Its LegitScript seal is an image on its own site, not a seal served by LegitScript, so the certification isn't shown independently
- The terms describe monthly auto-refills, while the cancellation policy describes a 3-month membership
- No refunds on compounded medication once it ships, and lab work is billed separately
- Disputes go to binding individual arbitration
Is BioPivot worth it?
What BioPivot is selling, in one line, is published stage-by-stage compounded GLP-1 prices, with monthly, quarterly and microdose options. New patients start at $148/month for the first order, but the price steps up to $185/month once that window ends, so treat the headline number as an intro offer, not the standing rate. No single feature of its GLP-1 program sets it apart from the category on its own, so the price and terms below are the things to compare.
On top of the core program, it offers a microdosing option and names the pharmacy that fills its prescriptions.
How much BioPivot costs
- Compounded semaglutide starts at $148 for the first order, then $185/month after that, at that tier.
- Compounded tirzepatide starts at $193.60 for the first order, then $242/month after that, for that option.
Because BioPivot's headline figure is listed as “after intro offer”, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare BioPivot with the month-to-month prices of the alternatives below instead.
Brightmeds (about $189/month) is one of the closest alternatives to weigh BioPivot against.
Medications: what BioPivot prescribes
BioPivot prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.
Who BioPivot is best for, and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program and are comfortable comparing it against the alternatives below.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
BioPivot's intro price of $148 takes some of the cost out of the first order, but plan around the $185/month standing price, since that is what you pay from then on.
The Bottom Line
BioPivot scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with BioPivot?
From $185/mo (after intro offer). See current pricing and start your free consultation.
BioPivot might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare BioPivot vs…
BioPivot scores7.3/10
Side-by-side pricing, medications and scores. Pick a matchup.
BioPivot vs Amazon One Medical
Amazon One Medical scores 8.5/10
BioPivot vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this BioPivot review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See BioPivot's current pricing
Plans from $185/mo (after intro offer). Start your free consultation to check eligibility and today's price.